This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Martin L. Albert, MD; Nancy Helm-Estabrooks, ScD
Neurology Service and Audiology/Speech Pathology Service Veterans Administration Medical Center 150 S Huntington Ave Boston, MA 02130 Aphasia Research Center Department of Neurology Boston University School of Medicine 80 E Concord St Boston, MA 02118

Arch Neurol. 1988;45(4):372-373.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—With all due respect for Hartman and Landau¹ and their sincere effort to provide a scientific analysis of the benefits of aphasia therapy, their article misses the point. Aphasia therapy works; they did not study the problem properly.

It is unfortunate that they did not offer their patients the benefits of contemporary approaches to aphasia therapy. Just as Dr Landau would not want to limit his treatment of patients with Parkinson's disease to forms of therapy introduced in the 1950s, he and his associates should not limit their treatment of aphasic patients to forms of therapy described in the 1950s.² The last 15 years have witnessed the introduction of new forms of aphasia therapy as dramatic and successful as the introduction of levodopa for Parkinson's disease. Many of these aphasia therapies are syndrome specific^3-5 and based on knowledge of spared and impaired language and . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?